Serious Gilead / Remdesivir / Veklury and CDC conflicts of interests within the CDC/NIH Panel providing Covid-19 treatment guidance need more disclosure and investigation - why isnt it happening ?
Reported CDC / Gilead financial conflicts are set out in time limited CDC financial disclosure filings - link at the end
This conflict seems to extend to the top level of the CDC / NIH and is detailed and expanded in the docu video interview linked below by 5 times Emmy Award winning journalist
Gilead Conflicts
2 of the CDC / NIH Covid-19 Panels 3 co-chairs have long term links to Gilead which are not declared.
The third co-chair is Dr Clifford Lane who co-authored a postive study on Remdesivir as a Covid-19 treatment
However Dr Lane does not need to declare any indirect connections to Gilead or Remdesivir / Veklury on his CDC disclosures such as co-authoring papers finding in favor of Remdesivir
Further Dr Fauci and Dr Lane published a joint paper which was generally in favor of remdesivir and against hydroxychloroquine
Why is this important ?
The 3 co-chairs select the panel members who set out the Covid-19 treatment guidelines for the USA
8 members of the panel have currently declared financial links to Gilead the maker of Remsedivir - one treatment the CDC has promoted for use against Covid-19 (though some trials have been stopped and limited benefits shown)
In March 2020 - 9 Covid-19 panel memebers declared financial connections to Gilead.
web.archive.org
2 more Covid-19 panel members are said to be or have been on Gilead advisory bodies with financial connections which they are now not required to declare if there is no financial connection to the advisory aboard
For example in Dec 2018 a CDC financial link was declared to the Gilead Advisory Board by
Judith Aberg
Gilead (Advisory Board, Research Support)
This Advisory Board link is no longer required to be reported as it is over 11 months old and has no financial link associated with it despite reporting other Gilead financial links
CDC - Dec 2018 Gilead Advisory Board
web.archive.org
From the above CDC finacial disclosure it can clearly be seen that the Covid-19 co-chairs are on other important treatment panels working closely with many Gilead financially linked board advisors and researchers. While this may be understandable it shows how deeply Gilead and others have potential to influence within the CDC and NIH
Other members of the Covid panel are also said to have longer term connections with Gilead that they are not required to declare
Gilead was the Pharma Company with the most conflicts declared by Covid-19 Panel members - by a huge margin
For further details about the above Gilead conflicts see the link to docu video below by 5 times Emmy Award winning journalist - from around 7 minutes 50 seconds into the video
QUESTION
Are safe, and possibily effective and cheap medicines being pushed to one side in favor of expensive solutions that have not been shown to be effective.
CONCERNS
The CDCs relationship with big pharma is too close particularly at the level of reserchers and decision makers and the revolving door of jobs between the CDC and big pharma. CDC researchers and others own CDC funded patents
Further info at the end of this post about these conflicts
Dr Fauci owns 8 CDC funded patents and Dr Clifford Lane owns 4 and both receive annual payments from these patents.
After licensing the commercial rights to these Fauci/Lane patent treatments to drug maker Chiron Corp., (later bought by Norvartis) Fauci’s CDC division subsequently spent $36 million in taxpayer money testing the treatment on patients in one experiment alone.
Dr Clifford Lane is one of the 3 key co-chairs of the CDC Covid-19 Guidance Panel.
National Institute of Allergy and Infectious Diseases Director Anthony Fauci and NIAID Deputy Director H. Clifford Lane since 1997 received royalties of $45,072.82 each for the development of interleukin-2, an AIDS treatment they invented with NIH physician Joseph Kovacs.
Other Countries
Similar Gilead conflicts have been highlighted and reported in France amongst leading French Drs - see link to paper submitted for peer review below
The paper sets out a review of payments made by Gilead to 98 leading French Drs correlated with how they did not support the use of Hydroxychloroquine in France - which is seen as an alternative to Remdesivir.
Note only 13 of these 98 French Drs did not declare a financial connection with Gilead.
A. the 13 Drs who received the biggest financial payments from Gilead were publically most strongly against the use of Hydroxychloroquine in France - high correlation
B. the 13 Drs who received no payments from Gilead most were strongly in favor of the use of Hydroxychloroquine in France - high correlation
See links below
Emmy Award Winning Journalist Interviews
View: https://m.youtube.com/watch?v=zB-_SV-y11Y
CDC Official Financial Conflict Disclosure with Gilead
web.archive.org
French Gilead Financial Conflict Paper
www.sciencedirect.com
Further Info on CDC Funded Patents and Conflicts
Over many years Congress, the Inspector General of Health and Human Services, Whistleblowers and Journalists have reported huge failings in transparency and conflicts of interest at the CDC. Little seems to have changed over the years as confirmed by whistleblower disclosures etc.
Its long overdue to have full transparency with disclosure of all historic payments and relationships made (not time limited) - the pharma company should have these records
One physician who voted to recommend the rotavirus vaccine on the FDA’s advisory committee received $255,000 per year in research funds from the maker of the vaccine, Wyeth Lederle. She received a waiver from the FDA to vote on the issue because her research for Wyeth focused on other vaccines.
One member of the CDC’s advisory committee who was not allowed to vote on the rotavirus vaccine because of a conflict was allowed to participate in closed-door working group meetings that drafted the committee’s recommendations for the vaccine. He was also allowed to make an impassioned plea for approval of the vaccine at the full committee meeting.
Another member of the CDC’s advisory committee held a lucrative patent on a rival rotavirus vaccine under development by Merck. Despite this conflict, the doctor voted three times on recommendations regarding Wyeth’s vaccine. It was not until the committee voted to rescind its recommendation of the rotashield that he recused himself because of a “perception of conflict.”
www.lawfirms.com
CDC members own numerous patents associated with vaccinations and regularly receive funding for their research work from the very same pharmaceutical companies who manufacturer vaccinations which are ultimately sold to the public. This situation creates an obvious conflict of interest, as members of the ACIP committee benefit financially every time a new vaccination is released to the market.
CDC members also own other medical patents paid for by CDC funds and then used or bought by big pharma . In 2005 387 then current members of the CDC were receiving royalty payments for work funded by the CDC and 51 were doing research on patients involving patents they had developed. Another 500 + ex CDC memebers were also receiving royalty payments.
Reported CDC / Gilead financial conflicts are set out in time limited CDC financial disclosure filings - link at the end
This conflict seems to extend to the top level of the CDC / NIH and is detailed and expanded in the docu video interview linked below by 5 times Emmy Award winning journalist
Gilead Conflicts
2 of the CDC / NIH Covid-19 Panels 3 co-chairs have long term links to Gilead which are not declared.
The third co-chair is Dr Clifford Lane who co-authored a postive study on Remdesivir as a Covid-19 treatment
However Dr Lane does not need to declare any indirect connections to Gilead or Remdesivir / Veklury on his CDC disclosures such as co-authoring papers finding in favor of Remdesivir
Further Dr Fauci and Dr Lane published a joint paper which was generally in favor of remdesivir and against hydroxychloroquine
Why is this important ?
The 3 co-chairs select the panel members who set out the Covid-19 treatment guidelines for the USA
8 members of the panel have currently declared financial links to Gilead the maker of Remsedivir - one treatment the CDC has promoted for use against Covid-19 (though some trials have been stopped and limited benefits shown)
In March 2020 - 9 Covid-19 panel memebers declared financial connections to Gilead.
Financial Disclosure | Coronavirus Disease COVID-19
Find more information about the financial disclosures of the U.S. Department of Health and Human Services COVID-19 panel roster.
2 more Covid-19 panel members are said to be or have been on Gilead advisory bodies with financial connections which they are now not required to declare if there is no financial connection to the advisory aboard
For example in Dec 2018 a CDC financial link was declared to the Gilead Advisory Board by
Judith Aberg
Gilead (Advisory Board, Research Support)
This Advisory Board link is no longer required to be reported as it is over 11 months old and has no financial link associated with it despite reporting other Gilead financial links
CDC - Dec 2018 Gilead Advisory Board
Financial Disclosure Adult and Adolescent ARV
web.archive.org
From the above CDC finacial disclosure it can clearly be seen that the Covid-19 co-chairs are on other important treatment panels working closely with many Gilead financially linked board advisors and researchers. While this may be understandable it shows how deeply Gilead and others have potential to influence within the CDC and NIH
Other members of the Covid panel are also said to have longer term connections with Gilead that they are not required to declare
Gilead was the Pharma Company with the most conflicts declared by Covid-19 Panel members - by a huge margin
For further details about the above Gilead conflicts see the link to docu video below by 5 times Emmy Award winning journalist - from around 7 minutes 50 seconds into the video
QUESTION
Are safe, and possibily effective and cheap medicines being pushed to one side in favor of expensive solutions that have not been shown to be effective.
CONCERNS
The CDCs relationship with big pharma is too close particularly at the level of reserchers and decision makers and the revolving door of jobs between the CDC and big pharma. CDC researchers and others own CDC funded patents
Further info at the end of this post about these conflicts
Dr Fauci owns 8 CDC funded patents and Dr Clifford Lane owns 4 and both receive annual payments from these patents.
After licensing the commercial rights to these Fauci/Lane patent treatments to drug maker Chiron Corp., (later bought by Norvartis) Fauci’s CDC division subsequently spent $36 million in taxpayer money testing the treatment on patients in one experiment alone.
Dr Clifford Lane is one of the 3 key co-chairs of the CDC Covid-19 Guidance Panel.
National Institute of Allergy and Infectious Diseases Director Anthony Fauci and NIAID Deputy Director H. Clifford Lane since 1997 received royalties of $45,072.82 each for the development of interleukin-2, an AIDS treatment they invented with NIH physician Joseph Kovacs.
Other Countries
Similar Gilead conflicts have been highlighted and reported in France amongst leading French Drs - see link to paper submitted for peer review below
The paper sets out a review of payments made by Gilead to 98 leading French Drs correlated with how they did not support the use of Hydroxychloroquine in France - which is seen as an alternative to Remdesivir.
Note only 13 of these 98 French Drs did not declare a financial connection with Gilead.
A. the 13 Drs who received the biggest financial payments from Gilead were publically most strongly against the use of Hydroxychloroquine in France - high correlation
B. the 13 Drs who received no payments from Gilead most were strongly in favor of the use of Hydroxychloroquine in France - high correlation
See links below
Emmy Award Winning Journalist Interviews
CDC Official Financial Conflict Disclosure with Gilead
Financial Disclosure | Coronavirus Disease COVID-19
Find more information about the financial disclosures of the U.S. Department of Health and Human Services COVID-19 panel roster.
French Gilead Financial Conflict Paper
ScienceDirect.com | Science, health and medical journals, full text articles and books.
Further Info on CDC Funded Patents and Conflicts
Over many years Congress, the Inspector General of Health and Human Services, Whistleblowers and Journalists have reported huge failings in transparency and conflicts of interest at the CDC. Little seems to have changed over the years as confirmed by whistleblower disclosures etc.
Its long overdue to have full transparency with disclosure of all historic payments and relationships made (not time limited) - the pharma company should have these records
One physician who voted to recommend the rotavirus vaccine on the FDA’s advisory committee received $255,000 per year in research funds from the maker of the vaccine, Wyeth Lederle. She received a waiver from the FDA to vote on the issue because her research for Wyeth focused on other vaccines.
One member of the CDC’s advisory committee who was not allowed to vote on the rotavirus vaccine because of a conflict was allowed to participate in closed-door working group meetings that drafted the committee’s recommendations for the vaccine. He was also allowed to make an impassioned plea for approval of the vaccine at the full committee meeting.
Another member of the CDC’s advisory committee held a lucrative patent on a rival rotavirus vaccine under development by Merck. Despite this conflict, the doctor voted three times on recommendations regarding Wyeth’s vaccine. It was not until the committee voted to rescind its recommendation of the rotashield that he recused himself because of a “perception of conflict.”
CDC Members Own More Than 50 Patents Connected to Vaccinations
A Medical Malpractice article.
www.lawfirms.com
CDC members own numerous patents associated with vaccinations and regularly receive funding for their research work from the very same pharmaceutical companies who manufacturer vaccinations which are ultimately sold to the public. This situation creates an obvious conflict of interest, as members of the ACIP committee benefit financially every time a new vaccination is released to the market.
CDC members also own other medical patents paid for by CDC funds and then used or bought by big pharma . In 2005 387 then current members of the CDC were receiving royalty payments for work funded by the CDC and 51 were doing research on patients involving patents they had developed. Another 500 + ex CDC memebers were also receiving royalty payments.
Report: Researchers mumon financial interests
Government scientists have collected millions of dollars in royalties for experimental treatments without having to tell patients testing the treatments that the researchers’ had a financial connection, according to documents and interviews.
www.nbcnews.com
Last edited:
Facebook
Twitter
Instagram